ArticleJournal of the National Cancer Institute2010
Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?
Article in Journal of the National Cancer Institute, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Design, Synthesis, and Biological Activity of Novel Ornithine Decarboxylase (ODC) Inhibitors.Journal of medicinal chemistry · 2025Article
- Evaluation of the Cancer-Preventive Effect of Resveratrol-Loaded Nanoparticles on the Formation and Growth of In Vitro Lung Tumor Spheroids.Pharmaceutics · 2024Article
- Polyamine Biosynthetic Pathway as a Drug Target for Osteosarcoma Therapy.Medical sciences (Basel, Switzerland) · 2018Article
- Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.Journal of radiological protection : official journal of the Society for Radiological Protection · 2014Review
- Controlled-release systemic delivery - a new concept in cancer chemoprevention.Carcinogenesis · 2012Article
- Advanced drug delivery systems of curcumin for cancer chemoprevention.Cancer prevention research (Philadelphia, Pa.) · 2011Review
- Back to the future: mechanism-based, mutation-specific combination chemoprevention with a synthetic lethality approach.Cancer prevention research (Philadelphia, Pa.) · 2011Article
- Review of Network Meta-Analyses on the Efficacy of Chemopreventive Agents on Colorectal Adenomas and Cancer.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21115881What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.